Monthly Archives: February 2009

Yaz Spoofed on Best Week Ever

VH1 took Bayer to task on last night’s Best Week Ever, mocking the company’s new corrective ad for the contraceptive Yaz. Host Paul F. Tompkins introduced the skit by playing the opening few seconds of the actual television ad, in which a paid actress states, “You may have seen some Yaz commercials recently that were […]
Posted in Marketing | Tagged , , , , , , | 2 Comments

Astellas Keeps After CV Therapeutics

Astellas bid for CV Therapeutics turned hostile this morning when the Japanese drug firm offered $1 billion dollars for the company directly to shareholders. The CVT board rejected Astellas’s second proposal last Friday stating that the Astellas proposal undervalued the company and is not in the best interest of the shareholders. In a press release […]
Posted in Deals | Tagged , , , , , , , | Leave a comment

Acorda Seeking NDA for MS Drug

Hawthorne, NY-based Acorda Therapeutics yesterday released Phase III clinical trial data of fampridine-SR, a novel treatment that improves walking ability in Multiple Sclerosis patients. Acorda filed a New Drug Application for fampridine on January 30, and FDA approval is expected in about 10 months. If green-lighted, fampridine will be the first drug approved with the […]
Posted in Biotech | Tagged , , | Leave a comment

Witty Proposes Price Cap for Poor Nations

GlaxoSmithKline CEO Andrew Witty proposed Friday to slash drug prices in the world’s 50 poorest countries and reinvest 20 percent of the profits in bolstering local health care. In a speech at Harvard Medical School Friday, Witty said drug prices will be capped at 25 percent of what they cost in developed nations. He also […]
Posted in Corporate Responsibility, Emerging Markets, People | Tagged , , , | Leave a comment

Dunsire Named HBA Woman of the Year

The Healthcare Businesswomen’s Association (HBA) today announced that Dr. Deborah Dunsire, president and CEO of Millennium: The Takeda Oncology Company, will be honored as the 2009 Woman of the Year. Dunsire, a 20-year veteran of biologics and pharmaceutical business, was named president and CEO of Millennium in July 2005. She has received numerous awards for […]
Posted in Events | Tagged , , , | 1 Comment
  • Categories

  • Meta